EN
HI

UNJHA FORMULATIONS Share price

UNJHAFOR

HealthcareSmall

23.5

0.96 (4.26%)
Last updated on 23 May, 2025 | 15:29 IST
BUYSELL
Today's High

23.90

Today's Low

22.50

52 Week Low

19.99

52 Week High

39.00

The current prices are delayed, login to your account for live prices

Unjha Formulations Chart

UNJHA FORMULATIONS Share Key Metrics

Volume
881.00
Market Cap
10.10 CR
LTQ@LTP
1@23.50
ATP
22.82
Var Margin
29.66 %
Circuit Range
18.04-27.04
Delivery %
0 %
Value
20104.42
ASM/GSM
No
Market Lot
1

UNJHA FORMULATIONS Futures & Options

Data Not Found

UNJHA FORMULATIONS Corporate Actions

DateAgenda
2025-05-16Audited Results
2025-03-17Others
2025-02-04Quarterly Results
DateEvent TypeAgenda
2025-05-16Board MeetingAudited Results
2025-03-17Board MeetingOthers
2025-02-04Board MeetingQuarterly Results

UNJHA FORMULATIONS News

No Data Found

About UNJHA FORMULATIONS

NSE : 0  
BSE : 531762  
ISIN : INE576D01015  

M/s. Unjha Formulations Limited was established in June 1987as a partnership firm for manufacturing PharmaceuticalFormulations at Khali Char Rasta Tal: SidhpurDist: Mehsana. The firm has now been converted into aPublic Limited Company vide Certificate of IncorporationNo.04/22932 of 1994-95 dated 2.9.94. The company ispresently manufacturing pharmaceutical formulations likeliquids powder tablets capsules injectibles etc. TheCompany is one of the largest manufacturers of Isabgulproducts in India. The company is located in the heart ofIsabgul growing region worldwide.The Company has seen uninterrupted growth sinceincorporation and the sales have consistently risen fromRs.85 lacs in 1991-92 to Rs.348.50 lacs in 1994-95. TheCompany is presently manufacturing an extensive range ofPharmaceutical Formulations for human consumption and forveteniary use. The sales therefore are divided into the twosegments viz: human consumption and veterinary products.In the proposed expansion programme the company proposesto manufacture additional tablets and injectibles for humanconsumption and also catering veterinary market. Thecompany has identified the market segment for veterinarydrugs as a less competitive market. Other Companiespromoted by the promoter are in the business of procuringand trading in Psyllium husk. The Company procures thisprocessed husk for its various products. Therefore thereis no conflict of interest. Also not all the raw materialis procured from companies promoted by the same promotersand procurement is based on best rates available."Gelax" is one of the main products of the companycatering to the domestic market. The Company has signed aMOU with the Indian Immunological Hyderabad (a unit of theNational Dairy Development Board) for the offtake of theirproducts.The Company has seen its exports continuously increase fromRs.5.52 lacs in 1991-92 to Rs.38.56 lacs in 1994-95. Thecompany has received Export Orders from Companies in Kenyaand Dubai for Magnesium Silicate Compound and IsabgulProducts worth Rs.46.10 lacs. The Company is operating in an industry where there aremajor pharmaceutical companies - both Indian andMultinational - operating. However the company has aninherent advantage in that it is located in the heart ofthe Isabgul growing regions in the world with promoterswell experienced in the procurement of Psyllium Husk - themajor raw material for the company''s products. Also it hasfirm marketing tie up with a major concern which has a strongbrand image.

UNJHA FORMULATIONS Management

NamePosition
Mrs. Jashodaben S Patel Chairman
Mrs. Krutiben M Patel Managing Director
Ms. Esha M Patel Director
Mr. Hashmukh S Darji Director
Mr. Jitendra P Lambachiya Director
Read More

UNJHA FORMULATIONS FAQs

The Buying Price of UNJHA FORMULATIONS share is 23.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy UNJHA FORMULATIONS share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of UNJHA FORMULATIONS shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio UNJHA FORMULATIONS shares is 0. Useful to assess the stock's value relative to its book value.

To assess UNJHA FORMULATIONS’s valuation compare Sector P/E, P/B which are 30.11 & 3.8 with sector averages, along with growth rates and financial metrics.

The Market Cap of UNJHA FORMULATIONS is 10.10 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of UNJHA FORMULATIONS share price is 39.00 & 19.99. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.